WhisperX tag archive

#医药流通

This page collects WhisperX intelligence signals tagged #医药流通. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.

Latest Signals (2)

The Vault · 2026-03-27 05:39:14 · 重药控股

1. Over $49 billion worth of debt service pressure and liquidity risk continues to rise in 2026 for the HRU.

In the south-west region, the annual financing plan announcement issued on 11 March 2026 by the well-established Medicines Enterprise Remedial Unit, revealed that the proposed financing for 2026 amounted to RMB 20,490 million and that the subsidiaries intended to finance 28,910 billion yuan, totalling RMB 49.4 billion....

The Vault · 2026-03-30 05:39:30 · 澎湃新闻 (RSSHub)

2. 九州通旗下重庆万州公司因政府采购恶意串通被罚,列入不良记录并禁入一年

九州通医药集团旗下公司因在政府采购项目中恶意串通,遭到严厉处罚。重庆市云阳县财政局近日公布,九州通医药集团重庆万州有限公司在“云阳县人民医院关节外科计算机导航系统”采购项目中,存在与其他供应商恶意串通的违法行为。这一行为直接导致该公司被处以采购金额千分之五的罚款,共计12750元,并被列入政府采购不良行为记录名单,未来一年内禁止参加所有政府采购活动。 此次涉事主体为九州通医药集团重庆万州有限公司,该公司成立于2015年,其法定代表人为黄小娇。股权穿透显示,该公司由重庆九州通医药有限公司控股,后者又隶属于九州通医药投资(湖北)有限公司,最终均指向A股上市公司九州通(600998.SH)。这意味着此次违规行为直接关联到国内知名的医药流...